
Dec. 10, 2011Cell Therapeutics ASH Analyst/Investor Meeting
11:15 a.m. PSTWebcast
Nov. 11, 2011Cell Therapeutics, Inc. (CTI) to hold Annual Meeting
1 p.m. ESTInformation about Annual Meeting
Annual Meeting Webcast
Oct. 25, 2011Cell Therapeutics, Inc. (CTI) to Report Third Quarter 2011 Financial Results
8:30 a.m. EDTWebcast
Oct. 25, 2011Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO Investor Forum
2:30 p.m. EDTWebcast
Sept. 12, 2011Cell Therapeutics, Inc. (CTI) to Present at 13th Annual Rodman & Renshaw Healthcare Conference
2 p.m. EDTWebcast
July 28, 2011Second Quarter Financial Results
8:30 a.m. EDTHear Webcast
June 14, 2011 PIXANTRONE appeal update Read press release
May, 3, 2011Conference Call Update on PIXANTRONE
View Webcast
June 4, 2011Investor Webcast - TOSEDOSTAT OverviewView Webcast
Cell Therapeutics, Inc. is continuing the clinical development of pixantrone by planning an additional Phase III trial with pixantrone in aggressive NHL. The trial will be an international, multicenter, randomized, active-controlled, single-blind (open label to patients and investigators only) study comparing the efficacy and safety of pixantrone treatment with that of a comparator arm.
If you would like more information about this trial, including sites in your area when it is available, please submit the following form to stay updated.